<DOC>
	<DOCNO>NCT01392677</DOCNO>
	<brief_summary>This study intend compare efficacy safety dapagliflozin versus placebo patient type 2 diabetes inadequate glycaemic control background combination metformin sulfonylurea .</brief_summary>
	<brief_title>Evaluation Safety Efficacy Dapagliflozin Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control Background Combination Metformin Sulfonylurea</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Type 2 diabetes mellitus Men woman age ≥ 18 year old Stable dose combination metformin sulfonylurea HbA1c ≥7.7 % ≤11.0 % Type 1 diabetes mellitus diabetes insipidus Recent cardiovascular event Kidney urological disorder Hepatic disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>dapagliflozin</keyword>
	<keyword>diabetes</keyword>
	<keyword>hyperglycaemia</keyword>
</DOC>